Vetnuus | February 2026 21 These limitations have been a long-standing challenge for countries such as South Africa, where effective disease control must be balanced with the need to maintain transparency, confidence, and access to export markets. What Are DIVA Vaccines – and Why Do They Matter? DIVA vaccines (Differentiating Infected from Vaccinated Animals) are designed to overcome this challenge. They protect animals against Foot-andMouth Disease while still allowing veterinarians and authorities to reliably identify animals that have been exposed to the live virus. Unlike traditional vaccines, DIVA vaccines exclude certain viral components. This means diagnostic tests can clearly distinguish between antibodies produced through vaccination and those produced through infection. For South African livestock management, DIVA vaccines are particularly important because they: • strengthen disease surveillance and early detection, even in vaccinated populations; • allow for more targeted outbreak control, reducing unnecessary restrictions; • support international trade, where proof of disease freedom is essential; and • enable vaccination strategies that do not undermine confidence in disease reporting. In a country managing both endemic risk and trade sensitivity, DIVA vaccines offer a practical way to improve transparency, trust, and long-term resilience in the livestock sector. What’s Expected in 2026 South Africa is preparing for the introduction of oil-based, DIVA-compatible FMD vaccines, expected to become available in early 2026, subject to regulatory approval. These vaccines are anticipated to provide longer-lasting immunity than current water-based formulations, making them more suitable for breeding herds and dairy operations. The availability of DIVA vaccines is expected to be a significant step forward for the livestock industry, enabling more strategic vaccination programmes while maintaining robust surveillance and supporting the country’s efforts to regain and protect market access. Strengthening Long-Term Vaccine Capacity Beyond immediate vaccine supply, government has indicated plans to strengthen domestic vaccine production capacity as part of a broader national biosecurity strategy. Expanding local manufacturing and diversifying vaccine options will be key to improving South Africa’s preparedness for future outbreaks and reducing reliance on emergency imports. Conclusion While current vaccines remain essential for outbreak response, the introduction of DIVA-compatible vaccines will significantly strengthen South Africa’s ability to manage FMD, protect trade, and build a more resilient livestock sector. v Article
RkJQdWJsaXNoZXIy OTc5MDU=